tiprankstipranks
HCA Healthcare (HCA)
NYSE:HCA
US Market
HCA
HCA Healthcare
RESEARCH TOOLSreports
Want to see HCA full AI Analyst Report?

HCA Healthcare (HCA) Stock Forecast & Price Target

1,791 Followers
See the Price Targets and Ratings of:

HCA Analyst Ratings

Moderate Buy
14Ratings
Moderate Buy
10 Buy
4 Hold
0 Sell
Based on 14 analysts giving stock ratings to
HCA
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HCA Stock 12 Month Forecast

Average Price Target

$523.14
▲(7.20% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $523.14 with a high forecast of $635.00 and a low forecast of $436.00. The average price target represents a 7.20% change from the last price of $488.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"339":"$339","636":"$636","413.25":"$413.3","487.5":"$487.5","561.75":"$561.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":635,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$635.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":523.1428571428571,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$523.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":436,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$436.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[339,413.25,487.5,561.75,636],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,474.75,487.0769230769231,499.40384615384613,511.7307692307692,524.0576923076923,536.3846153846154,548.7115384615385,561.0384615384615,573.3653846153846,585.6923076923077,598.0192307692307,610.3461538461538,622.6730769230769,{"y":635,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,474.75,478.4725274725275,482.19505494505495,485.9175824175824,489.6401098901099,493.3626373626374,497.08516483516485,500.80769230769226,504.53021978021974,508.2527472527472,511.9752747252747,515.6978021978022,519.4203296703297,{"y":523.1428571428571,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,474.75,471.7692307692308,468.78846153846155,465.8076923076923,462.8269230769231,459.84615384615387,456.86538461538464,453.88461538461536,450.90384615384613,447.9230769230769,444.9423076923077,441.96153846153845,438.9807692307692,{"y":436,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":343.42,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":340.748,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":379.607,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":387.68,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":355.274,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":402.041,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":424.805,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":458.315,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":501.507,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":466.166,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":496.112,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":532.128,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":474.75,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$635.00Average Price Target$523.14Lowest Price Target$436.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stephens Analyst forecast on HCA
Unknown Analyst
Stephens
Not Ranked
Stephens
$530
Buy
8.61%
Upside
Assigned
04/27/26
HCA Healthcare price target lowered to $530 from $560 at StephensHCA Healthcare price target lowered to $530 from $560 at Stephens
Truist Financial Analyst forecast on HCA
David S Macdonald
Truist Financial
Truist Financial
$546→$535
Buy
9.63%
Upside
Reiterated
04/27/26
Analysts Are Bullish on These Healthcare Stocks: Pelthos Therapeutics (PTHS), HCA Healthcare (HCA)
Oppenheimer Analyst forecast on HCA
Michael Wiederhorn
Oppenheimer
Oppenheimer
$540→$520
Buy
6.56%
Upside
Assigned
04/27/26
HCA Healthcare price target lowered to $520 from $540 at OppenheimerHCA Healthcare price target lowered to $520 from $540 at Oppenheimer
Bank of America Securities Analyst forecast on HCA
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$540→$480
Hold
-1.64%
Downside
Reiterated
04/27/26
HCA Healthcare price target lowered to $480 from $540 at BofAHCA Healthcare price target lowered to $480 from $540 at BofA
Bernstein Analyst forecast on HCA
Lance Wilkes
Bernstein
Bernstein
$541→$503
Hold
3.07%
Upside
Reiterated
04/27/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Intellia Therapeutics (NASDAQ: NTLA), Biogen (NASDAQ: BIIB) and HCA Healthcare (NYSE: HCA)
Wells Fargo Analyst forecast on HCA
Stephen Baxter
Wells Fargo
Wells Fargo
$481→$436
Hold
-10.66%
Downside
Assigned
04/27/26
HCA: Baxter Maintains Hold as Soft Underlying Trends Prompt Trimmed EBITDA Outlook and Price Target Cut to $436
KeyBanc Analyst forecast on HCA
Matthew Gillmor CFA
KeyBanc
KeyBanc
$550→$510
Buy
4.51%
Upside
Reiterated
04/27/26
Analysts Offer Insights on Healthcare Companies: ICU Medical (NASDAQ: ICUI), HCA Healthcare (NYSE: HCA) and Eli Lilly & Co (NYSE: LLY)
TD Cowen Analyst forecast on HCA
Ryan Langston
TD Cowen
TD Cowen
$561→$500
Buy
2.46%
Upside
Assigned
04/27/26
Analyst Reaffirms Buy on Resilient Fundamentals and 2026 Outlook Despite Temporary Headwinds, While Lowering Price Target to $500
Barclays Analyst forecast on HCA
Andrew Mok CFA
Barclays
Barclays
$551→$496
Buy
1.64%
Upside
Assigned
04/27/26
Analysts Offer Insights on Healthcare Companies: Boston Scientific (NYSE: BSX), Resmed (NYSE: RMD) and HCA Healthcare (NYSE: HCA)
RBC Capital Analyst forecast on HCA
Ben Hendrix
RBC Capital
RBC Capital
$593→$534
Buy
9.43%
Upside
Reiterated
04/26/26
RBC Capital Keeps Their Buy Rating on HCA Healthcare (HCA)
Jefferies Analyst forecast on HCA
Brian Tanquilut
Jefferies
Jefferies
$590→$525
Buy
7.58%
Upside
Reiterated
04/24/26
HCA Healthcare price target lowered to $525 from $590 at JefferiesHCA Healthcare price target lowered to $525 from $590 at Jefferies
Mizuho Securities Analyst forecast on HCA
Ann Hynes
Mizuho Securities
Mizuho Securities
$540→$585
Buy
19.88%
Upside
Reiterated
02/25/26
HCA Healthcare price target raised to $585 from $540 at MizuhoHCA Healthcare price target raised to $585 from $540 at Mizuho
UBS Analyst forecast on HCA
A.J. Rice
UBS
UBS
$598→$635
Buy
30.12%
Upside
Reiterated
02/23/26
HCA Healthcare price target raised to $635 from $598 at UBSHCA Healthcare price target raised to $635 from $598 at UBS
J.P. Morgan Analyst forecast on HCA
Benjamin Rossi
J.P. Morgan
J.P. Morgan
$420→$535
Hold
9.63%
Upside
Reiterated
02/20/26
HCA Healthcare price target raised to $535 from $420 at JPMorganHCA Healthcare price target raised to $535 from $420 at JPMorgan
Morgan Stanley Analyst forecast on HCA
Craig Hettenbach
Morgan Stanley
Morgan Stanley
$425
Sell
-12.91%
Downside
Reiterated
01/28/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), HCA Healthcare (NYSE: HCA) and Intuitive Surgical (NASDAQ: ISRG)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stephens Analyst forecast on HCA
Unknown Analyst
Stephens
Not Ranked
Stephens
$530
Buy
8.61%
Upside
Assigned
04/27/26
HCA Healthcare price target lowered to $530 from $560 at StephensHCA Healthcare price target lowered to $530 from $560 at Stephens
Truist Financial Analyst forecast on HCA
David S Macdonald
Truist Financial
Truist Financial
$546→$535
Buy
9.63%
Upside
Reiterated
04/27/26
Analysts Are Bullish on These Healthcare Stocks: Pelthos Therapeutics (PTHS), HCA Healthcare (HCA)
Oppenheimer Analyst forecast on HCA
Michael Wiederhorn
Oppenheimer
Oppenheimer
$540→$520
Buy
6.56%
Upside
Assigned
04/27/26
HCA Healthcare price target lowered to $520 from $540 at OppenheimerHCA Healthcare price target lowered to $520 from $540 at Oppenheimer
Bank of America Securities Analyst forecast on HCA
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$540→$480
Hold
-1.64%
Downside
Reiterated
04/27/26
HCA Healthcare price target lowered to $480 from $540 at BofAHCA Healthcare price target lowered to $480 from $540 at BofA
Bernstein Analyst forecast on HCA
Lance Wilkes
Bernstein
Bernstein
$541→$503
Hold
3.07%
Upside
Reiterated
04/27/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Intellia Therapeutics (NASDAQ: NTLA), Biogen (NASDAQ: BIIB) and HCA Healthcare (NYSE: HCA)
Wells Fargo Analyst forecast on HCA
Stephen Baxter
Wells Fargo
Wells Fargo
$481→$436
Hold
-10.66%
Downside
Assigned
04/27/26
HCA: Baxter Maintains Hold as Soft Underlying Trends Prompt Trimmed EBITDA Outlook and Price Target Cut to $436
KeyBanc Analyst forecast on HCA
Matthew Gillmor CFA
KeyBanc
KeyBanc
$550→$510
Buy
4.51%
Upside
Reiterated
04/27/26
Analysts Offer Insights on Healthcare Companies: ICU Medical (NASDAQ: ICUI), HCA Healthcare (NYSE: HCA) and Eli Lilly & Co (NYSE: LLY)
TD Cowen Analyst forecast on HCA
Ryan Langston
TD Cowen
TD Cowen
$561→$500
Buy
2.46%
Upside
Assigned
04/27/26
Analyst Reaffirms Buy on Resilient Fundamentals and 2026 Outlook Despite Temporary Headwinds, While Lowering Price Target to $500
Barclays Analyst forecast on HCA
Andrew Mok CFA
Barclays
Barclays
$551→$496
Buy
1.64%
Upside
Assigned
04/27/26
Analysts Offer Insights on Healthcare Companies: Boston Scientific (NYSE: BSX), Resmed (NYSE: RMD) and HCA Healthcare (NYSE: HCA)
RBC Capital Analyst forecast on HCA
Ben Hendrix
RBC Capital
RBC Capital
$593→$534
Buy
9.43%
Upside
Reiterated
04/26/26
RBC Capital Keeps Their Buy Rating on HCA Healthcare (HCA)
Jefferies Analyst forecast on HCA
Brian Tanquilut
Jefferies
Jefferies
$590→$525
Buy
7.58%
Upside
Reiterated
04/24/26
HCA Healthcare price target lowered to $525 from $590 at JefferiesHCA Healthcare price target lowered to $525 from $590 at Jefferies
Mizuho Securities Analyst forecast on HCA
Ann Hynes
Mizuho Securities
Mizuho Securities
$540→$585
Buy
19.88%
Upside
Reiterated
02/25/26
HCA Healthcare price target raised to $585 from $540 at MizuhoHCA Healthcare price target raised to $585 from $540 at Mizuho
UBS Analyst forecast on HCA
A.J. Rice
UBS
UBS
$598→$635
Buy
30.12%
Upside
Reiterated
02/23/26
HCA Healthcare price target raised to $635 from $598 at UBSHCA Healthcare price target raised to $635 from $598 at UBS
J.P. Morgan Analyst forecast on HCA
Benjamin Rossi
J.P. Morgan
J.P. Morgan
$420→$535
Hold
9.63%
Upside
Reiterated
02/20/26
HCA Healthcare price target raised to $535 from $420 at JPMorganHCA Healthcare price target raised to $535 from $420 at JPMorgan
Morgan Stanley Analyst forecast on HCA
Craig Hettenbach
Morgan Stanley
Morgan Stanley
$425
Sell
-12.91%
Downside
Reiterated
01/28/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), HCA Healthcare (NYSE: HCA) and Intuitive Surgical (NASDAQ: ISRG)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HCA Healthcare

3 Months
xxx
Success Rate
19/28 ratings generated profit
68%
Average Return
+6.68%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 67.86% of your transactions generating a profit, with an average return of +6.68% per trade.
1 Year
Whit MayoLeerink Partners
Success Rate
41/46 ratings generated profit
89%
Average Return
+25.60%
Copying Whit Mayo's trades and holding each position for 1 Year would result in 89.13% of your transactions generating a profit, with an average return of +25.60% per trade.
2 Years
xxx
Success Rate
46/46 ratings generated profit
100%
Average Return
+52.53%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +52.53% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HCA Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
26
18
22
23
17
Hold
9
11
11
11
9
Sell
0
2
2
2
0
Strong Sell
0
0
0
0
0
total
35
31
35
36
26
In the current month, HCA has received 17 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. HCA average Analyst price target in the past 3 months is 523.14.
Each month's total comprises the sum of three months' worth of ratings.

HCA Financial Forecast

HCA Earnings Forecast

Next quarter’s earnings estimate for HCA is $7.38 with a range of $6.80 to $7.60. The previous quarter’s EPS was $7.15. HCA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year HCA has Performed in-line its overall industry.
Next quarter’s earnings estimate for HCA is $7.38 with a range of $6.80 to $7.60. The previous quarter’s EPS was $7.15. HCA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year HCA has Performed in-line its overall industry.

HCA Sales Forecast

Next quarter’s sales forecast for HCA is $19.36B with a range of $18.76B to $19.75B. The previous quarter’s sales results were $19.11B. HCA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year HCA has Performed in-line its overall industry.
Next quarter’s sales forecast for HCA is $19.36B with a range of $18.76B to $19.75B. The previous quarter’s sales results were $19.11B. HCA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year HCA has Performed in-line its overall industry.

HCA Stock Forecast FAQ

What is HCA’s average 12-month price target, according to analysts?
Based on analyst ratings, HCA Healthcare’s 12-month average price target is 523.14.
    What is HCA’s upside potential, based on the analysts’ average price target?
    HCA Healthcare has 7.20% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is HCA a Buy, Sell or Hold?
          HCA Healthcare has a consensus rating of Moderate Buy which is based on 10 buy ratings, 4 hold ratings and 0 sell ratings.
            What is HCA Healthcare’s price target?
            The average price target for HCA Healthcare is 523.14. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $635.00 ,the lowest forecast is $436.00. The average price target represents 7.20% Increase from the current price of $488.
              What do analysts say about HCA Healthcare?
              HCA Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of HCA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.